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Cystic Fibrosis (CF), also known as mucoviscidosis, is the most 
common lethal genetic disease in Caucasians, affecting children and 
young adults, with a frequency of 1 in every 2500 newborns. The 
characteristic dysfunction in CF is the production of abnormally thick 
mucus by several epithelial cells, including the cells lining the 
respiratory tract, leading to obstruction of the pulmonary airways, and 
the development of recurrent bacterial infections. Progressive loss of 
lung function is responsible for 95% of the mortality. CF is also 
characterized by exocrine pancreatic insufficiency, male infertility and 
abnormal function of sweat glands, leading to an elevated electrolyte 
concentration in sweat, namely NaCl, which allows CF diagnostic at an 
early stage. Life expectancy and quality of life of CF patients have 
been improved in the past years, and the current management of the 
disease includes physical therapy, antibiotic administration and 
pancreatic enzyme replacement. 
The molecular basis of CF, which was elucidated in 1989 with the 
cloning of cystic fibrosis gene (CFTR), is defective Cl- transport in 
epithelia. The gene encodes the protein cystic fibrosis transmembrane 
conductance regulator (CFTR), a protein which functions as a cAMP 
and protein kinase A (PKA) regulated Cl- channel in the apical 
membrane of epithelial cells, and belongs to the ABC transporters 
superfamily. 
Despite the fact that there are more than a thousand mutations 
described, the most common mutation found in CF patients is a single 
deletion of a phenylalanine residue at position 508 (F508del), found in 
70% of all CF chromosomes, which leads to the retention of CFTR in 
the endoplasmic reticulum (ER). 
20 years of intensive scientific research revealed the complexity of 
the molecular mechanisms underlying CFTR trafficking and function 




monogenic disease continuously, in order to improve CF patients life 
expectancy and quality of life. 
In the past years, novel proteins that interact with CFTR have been 
intensively investigated for their roles in regulating CFTR traffic and 
function. Particular interest has been devoted to protein kinases, as 
they can generally become easily druggable. Among these kinases are 
adenosine monophosphate stimulated kinase (AMPK), casein-kinase 2 
(CK2) and spleen tyrosine kinase (SYK) as well as LMTK2. The MSc 
work described in this thesis focuses on the effects of the 
phosphorylation of CFTR by those kinases. 
The state-of-the-art concerning CF pathophysiology, CFTR 
structure, biogenesis, trafficking and function and the objectives of this 
work are presented in Chapter I, while Chapter II presents an overall 
description of the experimental procedures used throughout this work. 
Chapter IIII includes functional assays of CFTR variants with point 
mutations in putative phosphorylation consensus sites by CK2 or SYK, 
and the functional characterization of a non-disease causing CFTR 
variant, found in diabetic patients with pancreatitis. 
An integrative discussion of all results presented in this thesis is 
the issue of Chapter IV – including future directions and perspectives 
of the present work.  
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Cystic Fibrosis (CF), the most common lethal autosomal 
recessive disorder among Caucasians, is caused by mutations in the 
gene that encodes for the Cystic Fibrosis Transmembrane 
Conductance Regulator (CFTR). With more than 1600 mutations 
reported, a single mutation– the deletion of phenylalanine residue at 
position 508 – accounts for more than 70% of chromosomes worldwide. 
The presence of this mutation causes CFTR retention at the 
endoplasmic reticulum (ER) and its early degradation at the 
proteasome. 
We have studied the effect of AMPK phosphorylation on a CFTR 
variant (S573C) found in non-CF patients with pancreatitis. This variant 
was found to be less functional than wt-CFTR and more sensitive to 
AMPK phosphorylation. Our results suggest that S573 plays an 
important role in channel gating.  
We have also studied the effect of CK2 phosphorylation upon 
CFTR function and found that TBB inhibits wt-CFTR currents without 
affecting F508del-CFTR. Further insight was achieved by mutating 
three putative CK2-phosphorylation sites. (S422, S511 and T1471). 
Mutating S511 (A or D) did not have any detectable effect upon wt-
CFTR function, while mutating S422 (A or D) significantly , decreases 
or increases CFTR function, respectively. Both T1471A- and T1471D-
CFTR are less functional than wt-CFTR, and significantly inhibitable by 
TBB, similarly to S422 mutants. These data suggest that CK2 may be 
a positive effector for CFTR biogenesis, trafficking or function. 
Mutating Y512, the SYK consensus phosphorylation site, into an A 
results in a significant increase in CFTR function in both wt- and 
F508del backgrounds. This mutation may cause a conformational 




Altogether, these data provide novel insight into CFTR regulation 
by phosphorylation and thus to our understanding of the molecular 
mechanisms that govern its trafficking and/or function. 
 










A fibrose quística é a doença autossómica recessiva mais comum 
na população caucasiana, com uma incidência de 1:2500. Esta 
doença monogénica letal é caracterizada pela produção de muco 
extremamente espesso pelas células epiteliais que revestem os 
pulmões, que leva consequentemente à obstrução das vias aéreas e 
ao aparecimento recorrente de infecções bacterianas. A perda de 
função pulmonar é responsável por 95% da mortalidade. Além disso, a 
fibrose quística é também caracterizada por insuficiência pancreática 
exócrina, infertilidade masculina e funcionamento incorrecto das 
glândulas sudoríparas - elevando a concentração de electrólitos no 
suor, observação que está na base do mais clássico método de 
diagnóstico da doença - o teste do súor.  
Tanto a esperança média de vida como a qualidade de vida dos 
doentes de fibrose quística têm vindo a aumentar nos últimos anos, 
sobretudo devido aos avanços no controlo dos sintomas desta doença, 
sobretudo, incluindo fisioterapia, administração de antibióticos e 
suplementos enzimáticos. 
A base molecular desta doença foi elucidada em 1989 com a 
clonagem do gene que codifica para a proteína CFTR (Cystic Fibrosis 
Transmembrane Conductance Regulator). Esta proteína pertence à 
família dos transportadores ABC (ATP-binding cassette) e funciona 
como canal de cloreto activado por cAMP e PKA (Protein Kinase A), 
na membrana apical de células epiteliais. 
A ausência de secreção de cloreto pela proteína CFTR e a 
hiperabsorção de sódio através do canal epitelial de sódio (ENaC) 
levam a um aumento da absorção de água e consequente 
desidratação do muco que reveste as vias aéreas, aumentando a sua 
viscosidade e facilitando a colonização bacteriana. Desta forma, o 




levando a uma perda progressiva da função pulmonar e, em última 
análise, à morte. 
Dados mais recentes indicam que a CFTR está também envolvida 
na secreção de bicarbonato pelas células do ducto pancreático, 
apesar do mecanismo exacto pelo qual actua não ser consensual. A 
secreção de bicarbonato pode ocorrer directamente através da CFTR 
ou através da troca com cloreto, que será continuamente secretado 
pela CFTR para o lúmen do ducto pancreático. 
A CFTR contém 1480 resíduos de aminoácidos e é constituída por 
5 domínios: 2 domínios transmembranares (TMD) que formam o canal 
iónico, 2 domínios de ligação a nucleótidos (NBD), cada um com a 
capacidade de ligar uma molécula de ATP, essenciais para a abertura 
do canal, e um domínio de regulação (R), fosforilado por diversos 
cinases e principal responsável na regulação da função da CFTR- 
Apesar de existirem mais 1600 mutações descritas no gene CFTR, 
a mutação mais comum consiste na delecção de um resíduo de 
fenilalanina na posição 508 (F508del) da cadeia polipeptídica. Esta 
mutação, que está presente em 70% cerca dos cromossomas, causa 
a retenção da proteína CFTR no retículo endoplasmático e o seu 
rápido envio para degradação pela via da ubiquitina-proteassoma. 
Nos últimos anos, têm-se identificado proteínas que interagem 
com a CFTR e que regulam a sua biogénese, trafégo intracelular e 
função. Entre estes alguns cinases como AMPK (monophosphate 
stimulated kinase), CK2 (casein-kinase 2) e SYK (spleen tyrosine 
kinase) têm merecido interesse crescente. Nesta dissertação, 
pretende-se estudar o efeito da fosforilação por estes cinases na 
função da CFTR. 
O AMPK é um cinase ubíquo que fosforila resíduos de serina ou 
treonina. O AMPK é activado por uma diminuição dos níveis de ATP 
na célula, estimulando vias catabólicas que levam à produção de ATP 
e inibindo vias anabólicas que consomem ATP, quer através da 




expressão génica. O AMPK liga-se ao terminal carboxilo da proteína 
CFTR, fosforilando-a e inbindo a sua função como canal de cloreto. 
Os principais agonistas do AMPK são a metformina e fenformina, 
responsáveis por uma diminuição da produção de ATP na célula, 
através da inibição do complexo I da cadeia respiratória. 
O CK2 é um cinase heterotetramérico, constituído por duas 
subunidades catalíticas α ou α’ e duas subunidades regulatórias β, 
que fosforila resíduos de serina e treonina com a sequência de 
consensus Ser/Thr – X – X – Glu/Asp. O CK2 fosforila proteínas 
envolvidas na síntese, folding e degradação proteica e é inibido 
especificamente pelo tetrabromobenzotriazolo (TBB). Por ser uma 
proteína antiapoptótica, é um alvo hipotético para a criação e actuação 
de novos fármacos anti-cancerígenos. 
O SYK pertence à subfamília SYK/ZAP70 dos cinases de tirosina e 
participa em diversos processos de sinalização molecular através de 
receptores de células do sistema imunitário. O SYK é constituído por  
dois domínios SH2 seguidos de um domínio catalítico e fosforila 
resíduos de tirosina com a seguinte sequência de consensus Tyr – 
Asp/Glu – Asp/Glu. 
Em primeiro lugar, estudou-se o efeito da fosforilação de uma 
variante da CFTR (S573C) pelo cinase ubíquo AMPK. Esta mutação 
tem uma incidência aumentada em pacientes de pancreatite que não 
tinham fibrose quística. Os nossos resultados mostram que a proteína 
mutante resultante (S573C-CFTR) é menos funcional do que a 
proteína nativa (wt-CFTR) e mais sensível à metformina, um agonista 
do cinase AMPK usado no tratamento da diabetes mellitus tipo II. 
Consequentemente, o mutante S573C-CFTR parece ser sensível à 
fosforilação pelo AMPK. Os nossos resultados mostram também que a 
S573C-CFTR é regulada por alterações no pH intracelular de uma 
forma diferente da wt-CFTR, o que sugere que este resíduo, 
localizado no NBD1 da CFTR, tem especial relevância na ligação ao 




Posteriormente, estudou-se o efeito da fosforilação do CK2 na 
função da CFTR. A inibição específica deste cinase por TBB (4,5,6,7 – 
tetrabromobenziotriazolo) resultou numa diminuição da função da wt-
CFTR. No entanto, este composto não teve nenhum efeito na função 
da F508del-CFTR. 
Focámo-nos também o nosso estudo em três resíduos (S422, 
S511 e T1471), passíveis de fosforilação pelo CK2. Estes resíduos 
foram substituídos, por mutagénese dirigida, para resíduos de alanina 
(A) ou aspartato (D). A mutação do resíduo S511 quer para alanina 
quer para aspartato não teve nenhum efeito significativo na função da 
wt-CFTR. No entanto, a mutação do resíduo S422 para uma alanina 
diminuiu significativamente a função da wt-CFTR, enquanto que a 
mutação desta serina para aspartato a aumentou significativamente. 
Quanto ao resíduo T1471A, ambas as variantes produzidas são 
menos funcionais do que a wt-CFTR. Adicionalmente, os mutantes 
S422 e T1471 são inibidos pelo TBB, o que sugere que nenhum 
destes local é exclusivo para a fosforilação pelo CK2. 
No seu conjunto, estes dados sugerem que o CK2 pode ser um 
efector positivo da biogénese, tráfego e/ou função da CFTR. 
O nosso último objectivo foi estudar o efeito da fosforilação da 
CFTR pela SYK, mutando o único local de consensus encontrado na 
sequência da CFTR, o resíduo de tirosina na posição 512, para um 
resíduo de alanina (A), aspartato (D) ou fenilalanina (F). 
A mutação do resíduo Y512 quer para aspartato quer para 
fenilalanina não produziu qualquer efeito na activação da CFTR pelo 
cAMP. No entanto, ao mutar este resíduo para alanina vê-se um 
aumento significativo da actividade quer da wt-CFTR quer da F508del-
CFTR, o que sugere que esta mutação seja responsável por uma 
mudança conformacional na proteína que favorece a abertura do 
canal iónico. 
No seu conjunto, estes resultado contribuem para a compreensão 




objectivo de alargar a perspectiva sobre os mecanismos que regulam 
este canal iónico, e desta forma aumentar o conhecimento acerca dos 
mecanismos moleculares que regulam o processamento, tráfego e 
função da proteína CFTR. 
 








% v/v Percentage expressed in volume/volume 
% w/v Percentage expressed in weight/volume 
A Ampere 
A  Adenine residue 
aa. Aminoacid residue 
ABC ATP-binding cassette 
AFT  Arginine-framed tripeptide 
AMP  Adenosine monophosphate 
AMPK Adenosine monophosphate stimulated kinase 
ATP  Adenosine triphosphate 
Band B Core-glycosylated CFTR, ER-specific 
Band C Fully-glycosylated CFTR, post-Golgi 
BCR B-cell antigen receptor  
BHK Baby hamster kidney (cells) 
BSA Bovine serum albumin 
C Cytosine residue 
CA Carbonic anhydrase 
Calu-3 Cancer lung 3 cells 
cAMP cyclic adenosine monophosphate 
CC Compound C 
CCCP Carbonyl cyanide m-chloro phenyl hidrazone 
cDNA complementary DNA (to mRNA) 
CF Cystic Fibrosis 
CFBE Cystic fibrosis human bronchial epithelial cells 
CFTR Cystic Fibrosis transmembrane condutance regulator 
CFTR  Gene encoding CFTR 
CK2 Casein Kinase 2 
Cl- Chloride ion 
COP Coat Protein Complex 




DNA Deoxyribonucleic acid 
dNTP Deoxynucleoside triphosphate 
DOC Sodium deoxycholate 
dsDNA Double-stranded DNA 
DTT Dithiothreitol  
dTTP Deoxythymidine triphosphate 
E. Coli Escherichia coli 
EDTA Ethylenediaminetetraacetic acid 
ENaC Epithelial sodium channel  
ER Endoplasmic reticulum 
ERAD ER associated degradation 
ERQC ER quality control 
EtBr Ethidium bromide  
EtOH Ethanol 





G Guanine residue 
Glc Glucose 
GlcNAc N-acetylglucosamine 
Gm Conductance measured 
HeLa Henrietta Lacks cervical cancer cells 
hNBD1 Human NBD1 
HRP Horseradish peroxidase 
Hsc Heat shock cognate (protein) 
Hsp Heat shock protein 
I Electric current 
I- Iodide ion 
IBMX 3-Isobutyl-1-methylxantine 
kb Kilobase (1000 base pairs) 
kDa Kilodalton 
LMTK2 Lemur Tyrosine Kinase 2 
Man Mannose 
Met Metformin 
mRNA  Messenger RNA 
MSD Membrane spanning domain 
MTX  Metothrexate 
Na+  Sodium ion 
NBD Nucleotide binding domain 
ng nanograms 
NK Natural killer cell 
N-terminal Amino-terminal 
PAGE Polyacrilamide gel electrophoresis  
PBS Phosphate buffer saline 
PCR Polymerase chain reaction 
Phen Phenformin 
Pi Pirophosphate 
PI3K Phosphoinositide 3-kinase 
PKA Protein Kinase A 
PKC Protein Kinase C 
RD Regulatory domain 
RNA Ribonucleic Acid  
RT Room temperature 
S Siemens 
SDS Sodium dodecyl sulphate 
SEM Standard error of mean 
SH2 Src-homology 2 (domain) 
SLC Solute-link carrier 
SYK Spleen Tyrosine Kinase 
T Timine residue 
TBB tetrabromobenzotriazole, specific CK2 inhibitor 
TCA Trichloroacetic acid 
TEMED N,N,N,N’-tetrametilenodiamin 
Tris Tris(hidroximatil)aminometano 
Tween 20 Polyoxyethylene (20) sorbitan monolaurate 
UPP Ubiquitin proteasome system 
UV Ultraviolet 
V Volt 






















Chapter I –Introduction  
 
1. Cystic Fibrosis  
1.1. – Historical overview 
 
Cystic Fibrosis (CF) was firstly recognized as a separate disease in 
1938 when autopsy studies of malnourished infants revealed a disease 
of mucus plugging of the glandular ducts, which was named “cystic 
fibrosis of the pancreas”. Malabsorption of fat and proteins, poor 
growth and pulmonary infection were the major characteristics of this 
disease. The nutritional failure was considered to be caused by 
pancreatic damage and lack of pancreatic enzyme secretion, while the 
thick mucus clogging the gland ducts throughout the body raised the 
designation of “mucoviscidosis”. (Davis, 2006) (Quinton, 2007) 
1944 was the year of the identification of CF as a genetic disorder, 
by Dorothy Andersen. (Andersen, 1949;Quinton, 2007)  
In 1948, Paul di Sant’Agnese, a young assistant professor working 
with Andersen, was lead by a heat wave in New York to discover that 
the sweat of CF patients was abnormal and that there was an excess 
of sodium and chloride, up to a fivefold concentration. (di Sant'Agnese 
et al., 1953) 
This finding was very important because it provided the first 
diagnostic test, which is considered very robust, due to the fact that 
nearly every patient with CF has a high electrolyte concentration in 
sweat. (Davis, 2006) 
It was only in 1983 that the basic defect of CF was identified: Paul 
Quinton discovered that: “abnormally low Cl- permeability in cystic 
fibrosis leads to poor reabsorption of NaCl in the sweat duct, and 




Almost simultaneously, it was identified an increased absorption of 
sodium in the airways of CF patients as a common feature of CF. 
(Knowles et al., 1983) 
In 1989, the CF gene was cloned and predicted to encode for a 
protein, Cystic Fibrosis Transmembrane Conductance Regulator 
(CFTR) with two similar motifs, each one with “(i) a domain having 
properties consistent with membrane association and (ii) a domain 
believed to be involved in ATP (adenosine triphosphate) binding”. 
(Riordan et al., 1989) 
At the same time the most common mutation found in CF patients, 
F508del, was identified and found to have with an incidence of 70% – 
“A deletion of three base pairs that results in the omission of a 
phenylalanine residue at the center of the first predicted nucleotide-




Lung disease is the major cause of mortality in CF - airway 
obstruction by thick mucus and chronic infection by Pseudomonas 
aeruginosa, Burkholderia cepacia or Staphylococcus aureus, most of 
the time accompanied by severe inflammation. (Amaral and 
Kunzelmann, 2007;Accurso, 2006)  
The failure of Cl- secretion and the hyperabsorption of Na+ through 
the epithelial Na+ channel (ENaC) lead to an osmotic absorption of 
H2O. This dehydration of the periciliary liquid layer enhances its 
viscosity, inhibiting mucociliary clearance. Bacterial colonization 
happens easily in such an environment. (Knowles and Durie, 2002). 
The organism tends to develop a continuous inflammatory response, 
which further augments respiratory failure, and leads ultimately to 







Figure I.1. The CF pathogenesis cascade in the lung. A defective CFTR 
gene leads to an absent or deficient CFTR protein. The dysfunction in ionic 
transport leads to dehydration of periciliary layer, increasing its viscosity, 
impeding mucociliary clearance and allowing bacterial colonization. The 
continuous inflammatory response results in bronchiectasis and progressive 
lung insufficiency. From (Amaral and Kunzelmann, 2007) 
 
Most airway injury in CF is believed to be mediated by neutrophil 
products, including proteases and oxidants, liberated by the 




Although most patients die due to lung disease, non-respiratory 
manifestations are very important, such as exocrine pancreatic 
insufficiency, male infertility, and a form of intestinal obstruction named 
meconium ileus.(Collins, 1992) 
CF-related diabetes, which is thought to further contribute to lung 
disease, undernutrition and CF-related bone disease are also 
important complications of CF. .(Accurso, 2006) 
 
1.3. Diagnosis and treatment 
 
The major diagnostic test is the sweat test. However, there are 
some CF patients that have normal sweat sodium chloride 
concentrations, and further testing is required. Azoospermia in men, 
evidence of intestinal obstruction, assessment of liver function, 
identification of pan-sinusitis, or measurement of nasal potential 
difference, may confirm the diagnosis. (Davis, 2006) 
Nevertheless, definitive diagnosis depends on either sweat testing 
or identification of two mutant alleles in the CFTR. 
When CF was described, patients’ lives “were very short and 
painful”. (Davis, 2006) Presently, both duration and quality of life of CF 
patients have increased, due to the available treatments. 
Nutritional repletion is accomplished with pancreatic enzyme 
supplements, which were formulated in the late 1980s. However, the 
pancreatic supplements do not fully correct the malabsorption, due to 
acidification of intestinal contents, caused by impaired bicarbonate 
intestinal and pancreatic secretion in CF patients. Therefore, some 
blockers of gastric acid secretion may be prescribed to minimize 
stomach acidification. (Davis, 2006). 
Relief of airway obstruction is a major concern. Human DNase is 




cleaves free DNA which is one of the molecules that contribute to the 
stickiness of the mucus. (Davis, 2006). 
Administration of antibiotics is a major form of therapy in CF, and 
culture-specific antibiotics have been used for 60 years. The 
development of oral antibiotics such as the quinolone family for 
Pseudomonas and linezolid for Staphylococcus aureus has provided 
an effective alternative to intravenous administration. Nevertheless, 
formulation of antibiotics for aerosol use is preferentially chosen 
because higher antibiotic concentration is achieved and adverse 
effects are minimal. (Davis, 2006). (Accurso, 2006) 
Infection control remains a key issue in CF, so most patients are 
administrated with steroids or high-dose ibuprofen. (Davis, 2006). 
Most treatments are directed to the lower panels of Figure I.1. The 
current aim is to direct them at the upper panels. 
2. CFTR 
 
CFTR gene is located at the band 31 of the long arm of 
chromosome 7 (7q31).and spans a genomic region of 190 kb. (Tsui et 
al., 1985) (Tsui and Durie, 1997) 
The gene consists of 27 exons and encodes a transcript of 6,5 kb. 
CFTR expression is detected in lung, colon, sweat glands, placenta, 
liver, parotid glands, pancreas an in nasal polyp tissue, by mRNA gel-
blot hybridization. (Riordan et al., 1989) 
The resultant protein CFTR is 1480 amino acids residues long and 
has a molecular weight of approximately 180kDa, when fully 
glycosylated. (Powell and Zeitlin, 2002)  
Based on its structure, function and regulation, CFTR is a member 
of a large family of proteins – ATP-binding cassette (ABC) transporters, 
and is found in the apical side of epithelial cells, where it functions as a 




2.1. CFTR structure 
 
CFTR is composed of two membrane-spanning domains (MSDs), 
with six transmembrane α-helical segments each, and two nucleotide-
binding domains (NBDs) (Figure I.2 and Figure I.3) (Sheppard and 
Welsh, 1999) 
The presence of a regulatory domain (RD), which regulates CFTR 
activity upon phosphorylation, is a unique feature of CFTR, as a 
member of the ABC transporters family. (Riordan, 2005) 
MSDs are linked by 6 extracellular and 4 intracellular loops. The 
loop between transmembrane segment 7 and transmembrane 
segment 8 contains two consensus N-glycosylation sites. 
 
Figure I.2 - CFTR structure. Schematic representation of CFTR protein 
inserted into the cel membrane, showing the two membrane spanning 
domains, MSD1 and MSD2, the two nucleotide binding domains, NBD1 and 
NBD2 and the regulatory domain, RD. Glycosylation sites located in the 
extracellular loop between transmembrane segment 7 and transmembrane 
segment 8 are indicated by branched From (Li et al., 2007) 
2.2. CFTR Biogenesis, Processing and 
Trafficking 
 
The most common CFTR mutation, a single deletion of a 




protein misfolding, preventing CFTR from attaining its native global 
conformation. {Amaral, 2005). Therefore, F508del-CFTR is retained at 
the endoplasmic reticulum (ER) and sent to proteassomal degradation 
at an early stage. (Yang et al, 2003)  
Worldwide, current strategies to treat CF focus on correcting 
misfolding and early degradation. 
CFTR, along with other transmembrane glycoproteins, is co-
translationally inserted into the ER and N-linked to glycosyl groups. 
(Farinha et al., 2002) 
The chaperones Hsc70 (Heat shock cognate, 70 kDa) and Hsp70 
(Heat shock protein, 70 kDa) bind to the polypeptidic chain, co-
translationally, and assist the protein to acquire the proper folding. 
(Figure I.3). The presence of Hsp40 is required for CFTR stabilization 
and the prolonged retention of unfolded protein (F508del-CFTR, for 
instance) in the Hsc70 system targets it to degradation at an early 
folding checkpoint, involving CHIP and UbcH5a. (Farinha et al., 2002) 
(Farinha and Amaral, 2005) 
CHIP promotes ubiquitylation and degradation of misfolded CFTR 
in the association with the cytosolic E2 ubiquitin conjugating enzyme 
UbcH5a. (Ameen et al., 2007) 
CFTR seems to be particularly difficult in achieving a 
conformational state that fulfils all criteria that are necessary to 
proceed to the secretory pathway. While other ABC transporters, such 
as P-glycoprotein, mature and reach the membrane with great 
efficiency, CFTR matures inefficiently, as approximately 30% of the 
protein synthesised is fully glycosylated. (Riordan, 2008) 
The core CFTR glycosylation consists in the addition of 14-unit 
oligosaccharidic branched structure to consensus sequences (Asn-X-
Ser/Thr) in the nascent polypeptidic chain. These glycans are 
responsible for the interaction between the protein and different lectins, 





Export from the ER may involve additional checkpoints, namely the 
AFT-mediated retrieval/retention. It was shown that simultaneous 
mutation of 4 AFTs is able to rescue F508del-CFTR. (Figure I.3) 
(Amaral, 2005) (Farinha and Amaral, 2005a) (Roxo-Rosa et al., 2006) 
 
 
Figure I.3: Model of CFTR Biogenesis. CFTR is inserted in the ER 
membrane and binds Hsc70/Hsp40, and retention leads to proteasomal 
degradation, mediated by Hsc70-Chip-UbcH5a. Several rounds of glucose 
binding/release constitute the second checkpoint. When correctly folded, 
CFTR leaves the ER and proceeds to the secretory pathway, after being 
accessed for its folding at the last checkpoint. Adapted from (Farinha and 
Amaral, 2005) 
If CFTR is correctly folded it proceeds to the secretory pathway, 
while misfolded CFTR which is identified by the ERQC and degraded 
by the ubiquitin-proteasome pathway (UPP). (Amaral, 2005) 
The secretory pathway of eukaryotic cells is the sequential 
movement of a protein translocated into the ER through cis, medial¸ 
and trans Golgi apparatus.(Bannykh et al., 2000) 
Conventionally, CFTR and other proteins of the secretory pathway 




vesicular-tubular clusters (VTCs), which are then delivered at cis-Golgi. 
At this state VTCs-dependent recycling or COPI-independent retrieval 
may occur. However, the transport of cargo from VTCs along the Golgi 
is controversial, and Bannykh et al suggested that VTCs may bypass 
the cys- and medial-Golgi and reach the trans-Golgi or even 
endosomes. (Bannykh et al., 2000) 
The population of wt-CFTR that reach Golgi and post-Golgi 
compartments is quite stable. Moreover, CFTR pool in the cell 
membrane is rapidly internalized, at a rate of 10% per minute, which 
implies that CFTR must be recycled to the cell surface. CFTR 
molecules that are internalized follow the clathrin-coated vesicle 
endocytic pathway and are recycled or sent to lysosomal degradation. 
(Riordan, 2008) 
 
2.3. Classes of mutations and mutation-
specific therapies for treating CF 
 
More than 1,600 mutations in CFTR have been described to date. 
(http://www.genet.sickkids.on.ca/cftr). 
These mutations span throughout the entire gene but preferentially 
located in the regions that encode for the NBDs and the RD. F508del 
accounts for approximately 70% of chromosomes in CF patients, while 
the other CFTR mutations are very rare, with only four other mutations 
(G542X, N1303K, G551D and W1828X) having frequencies above 1%. 
(Rowntree and Harris, 2003) 
Mutations in the CFTR gene have, generally, been classified into 
five different groups according to the molecular mechanisms that lead 
to disease. 
Nowadays, several mutation specific strategies are under 
experimental/ clinical testing. 
Class I mutations affect CFTR biosynthesis and are, therefore, the 




(e.g., G542X), but also some frameshift and splicing mutations, 
prevent the biosynthesis of a stable protein or result in a truncated 
protein which is rapidly degradaded. (Rowntree and Harris, 2003) The 
strategy to suppress premature termination codons consists in the 
administration of aminoglycoside antibiotics, which enable the 
incorporation of an amino acid residue and permit the translation to 
continue. (Amaral and Kunzelmann, 2007) 
Class II mutations, including F508del, result in CFTR 
misprocessing and intracellular retention with concomitant delivery to 
degradative pathways thus resulting in a lack of functional protein at 
the apical cell membrane. (Rowntree and Harris, 2003). To assist the 
folding and enable CFTR to be correctly located at the cell membrane, 
pharmacological, molecular or chemical chaperones are being studied. 
These compounds are generally referred as correctors. (Amaral and 
Kunzelmann, 2007) 
CFTR bearing a class III mutation, G551D-CFTR for instance, 
reaches the cell membrane but does not respond to cAMP stimulation. 
Class III mutations are located in NBDs and are likely to prevent ATP 
binding or the coupling between ATP binding and channel gating. 
(Rowntree and Harris, 2003) To overcome the impaired gating, the 
strategy is to use compounds that stimulate pre-activated CFTR 
channel activity (potentiators) such as IBMX, an alkylxantine, and 
genistein, a naturally derived flavonoid (Amaral and Kunzelmann, 
2007) 
Class IV mutations, located in the MSDs, are the ones where 
CFTR is correctly located at the cell membrane and responds to cAMP 
stimulation but does not generate a proper Cl- conductance (R117H-
CFTR for example). Compensation for reduced conductance can be 
achieved by simultaneous traffic promotion and potentiators 
administration. (Amaral and Kunzelmann, 2007) 
Class V mutations result in a decrease of CFTR level and are often 




Splicing variants, such as G576A, which result in variable CFTR 
tissue-specific expression are also included in this class. (Rowntree 
and Harris, 2003) To overcome CFTR low levels, splicing factors that 
either promote normal exon inclusion or abnormal exon skipping 
should be used to augment protein synthesis. (Amaral and 
Kunzelmann, 2007) 




Figure I.4 – Functional classes of CF mutations. Class I mutations prevent 
translation. Class II mutations result in misfolded proteins, retained in the ER 
and rapidly degraded. CFTR bearing a class III or class IV mutation reaches 
the membrane but does not respond to cAMP stimulation or does or results in 
decreased Cl- conductance. Class IV mutations result in CFTR decrease. 








2.4. CFTR function 
 
When first identified, CFTR was considered to be the chloride 
channel defective in CF. 
This protein is a unique ABC transporter since it functions as a Cl- 
channel and is essential for absorption and secretion of salt across 
epithelia. CFTR also plays an important role in bicarbonate secretion 
either by being permeant to bicarbonate or by stimulating Cl-/HCO3- 
exchangers. (Riordan, 2008) 
 
2.4.1. CFTR as a chloride channel 
 
As stated above, CFTR major function as a cAMP activated and 
Protein Kinase A (PKA) regulated Cl- channel, in the apical membrane 
of epithelial cells. (Amaral and Kunzelmann, 2007) 
Single-channel analysis of wt-CFTR is characterized by bursts of 
channel openings, interrupted by brief closures and separated by 
longer closures between bursts. (Figure I.5) CFTR has a small single-
channel conductance (6-10 pS) and that the anion permeability 
sequence is Br- > Cl- > I- channel openings.(Sheppard and Welsh, 
1999). 
When F508del-CFTR is correctly located in the cell membrane it 
forms a channel with a gating defect, which suggests that the region 
around the phenylalanine at position 508 is involve in the engine that is 
responsible for the conformational changes that lead to the opening 









Figure I.5.: Representative single-channel traces of wt- and F508del-
CFTR in excised inside-out membrane patches from BHK cells. The upper dot 
line represents the closed state, while downward deflections correspond to 
channel openings. From (Roxo-Rosa et al., 2006) 
 
NBD1 and NBD2 use the energy of ATP hydrolysis to transport 
substrates across the cell membrane through diverse transmembrane 
pathways assembled from the MSDs, which form a Cl- selective 
channel gated by ATP binding. (Figure I.6)  
The two NBDs of CFTR function as a head-to-tail dimer with the 
ATP-binding sites located at the interface of the two subunits (Figure 
I.5). The association of NBD1 and NBD2 is required for optimal 
ATPase activity and channel gating by CFTR. (Li et al., 2007) 
CFTR is atypical both as an ion channel and as an ABC transporter 
since its activity is controlled by phosphorylation of the R domain. 
(Riordan, 2008) 
It was also shown that that the energy of ATP binding in the two 
catalytic sites seems to drive NBD1-NBD2 dimerization. (Vergani et al., 











Figure I.6.: Simplified model for CFTR-dependent Cl- transport across 
the cell membrane under quiescent and activated conditions. From (Li et al., 
2007) 
 
This structural arrangement leads to the opening of the Cl- 
permeation pathway in the transmembrane domains, and the NBD 
dimer would be stabilized by the two ATP complexes. Therefore, the 
hydrolosis of ATP at NBD2 would favor the dissociation of the complex 
and the closure of the pore and termination of the burst. (Figure I.7) 
(Vergani et al., 2003) 
 
Figure I.7.: Simplified scheme illustrating the mechanism of CFTR 








2.4.2. CFTR and bicarbonate secretion in 
the pancreas 
 
The pancreatic duct epithelium achieves the unique feature of 
secreting an almost isotonic sodium bicarbonate solution, in order to 
neutralize the gastric HCl. The low chime pH, as it reaches the small 
intestine, triggers secretion of the hormone secretin into the blood, 
which stimulates the bicarbonate secretion. 
Bicarbonate secretion by the pancreatic duct cells is certainly 
dependent on CFTR, though its exact role is still controversial. Some 
believe that bicarbonate permeability of CFTR may provide a pathway 
for bicarbonate efflux, while others state that bicarbonate secretion 
happens in exchange for Cl-, which is continuously being exported 
through CFTR. (Steward et al., 2005) 
The classic model for bicarbonate secretion by pancreatic duct 
cells, as it shown in Figure 2.3.1.1, considers that CO2 diffuses into the 
duct cell by the basolateral membrane, in first place. Then, carbonic 
anhydrase (CA) converts CO2  in H2CO3, which rapidly dissociates into 
H+ and HCO3- (bicarbonate). The resulting H+ leave the cell by an 
Na+/H+ exchanger, which is driven by the Na+ gradient, maintained by 
the Na+/K+-ATPase. The bicarbonate ions then leave the cell at the 
apical membrane in exchange for Cl- . The Cl- availability in the lumen 
is determined by CFTR. The membrane potential is maintained by 
basolateral K+ channels. (Steward et al., 2005) 
Nevertheless, very recently, Ishiguro et al have shown, using an 
electrophysiological approach that “CFTR functions as a bicarbonate 
channel in pancreatic duct cells, and provides a significant pathway for 
bicarbonate transport across the apical membrane”. (Ishiguro et al., 
2009) 
Impaired pancreatic bicarbonate secretion in pancreas confirms 







Figure I.8. Classic model for HCO3− secretion by pancreatic duct 
epithelium. In this model bicarbonate is secreted in exchange for Cl-, which is 
exported by CFTR. Adapted from (Steward et al., 2005) 
 
CFTR regulation by phosphorylation 
 
Phosphorylation and dephosphorylation are known to bo involved 
in the overall regulation of CFTR function. Phosphorylation of the R 
domain is the major mechanism that regulates CFTR activity. 
Apart from protein kinase A (PKA) several other kinases 
phosphorylate and activate CFTR such as Ca2+-dependent protein 
kinase C (PKC) and cyclic guanosine monophosphate dependent 
kinase (PKG). Recently, Faria et al reported the activation of CFTR 
through stimulation of the metabotropic purinergic receptor P2Y2, 
which occurs through an unknown kinase that is different from PKA 




Adenosine monophosphate stimulated kinase (AMPK) also 
regulates CFTR activity, inhibiting it through phosphorylation of two 
serine residues, S668 and S737. (Kongsuphol et al., 2009b) 
Several sites for casein kinase 2 (CK2) phosphorylation are also 
present. Three of them have been described: two serine residues, at 
position 422 and 511 (S422, S511) and one threonine residue at 
position 1471 (T1471). (Luz 2008) 
It has been shown by Pagano et al that S511 is not phosphorylated 
by CK2, which was found to phosphorylate S422 in NDB1, in vitro. 
(Pagano et al., 2008a) Moreover, T1471 was described as another 
CK2 putative phosphorylation site. (Ostedgaard et al., 2006).  
Spleen tyrosine kinase (SYK) may also have a role in CFTR 
regulation, since there is a SYK phosphorylation consensus sequence 




AMP-activated protein kinase (AMPK) is an ubiquitous Ser/Thr 
kinase and downstream molecule of a protein kinase cascade that is 
sensitive towards cellular energy. Upon ATP depletion, AMPK is 
activated and stimulates catabolic pathways that ultimately lead to ATP 
production and downregulates anabolic pathways that consume ATP, 
by direct phosphorylation of metabolic enzymes or by regulating gene 
expression. (Hallows et al., 2000;Hallows et al., 2003) 
AMPK binds to the cytoplasmic COOH terminal tail of CFTR and 
phosphorylates and inhibits CFTR channel activity predominantly 
through effects on CFTR gating. (Hallows et al., 2000;Hallows et al., 
2003) 
Several drugs have been used to activate AMPK in intact cells: 
metformin, phenformin and the nucleoside 5-aminoimidazole-4-
carboxamide-1-β-D-ribofuranoside (AICAR). (Woolhead et al., 2007). 




stimulated glucose uptake in muscle and lower hepatic glucose output. 
(Hawley et al., 2002;Mallick, 2004) 
Phenformin was used in the clinical treatment of type II diabetes, 
but it has been withdrawn from clinical use due the high incidence of 
lactic acidosis on patients treated with this drug. It was replaced by 
metformin, which still has some risk of lactic acidosis though. 
(Woolhead et al., 2007) (Mallick, 2004) 
Metformin, like phenformin, is believed to activate AMPK by 




CK2 is a pleiotropic kinase which phosphorylates serine and 
threonine residues with a consensus sequence Ser/Thr – X – X – 
Glu/Asp. This kinase phosphorylates molecular targets that are 
involved in protein synthesis, folding, degradation and proliferation 
processes. CK2 is well known for its anti-apoptotic role, suggesting 
that it might be a valuable target to develop anticancer drugs. (Pagano 
et al., 2008) 
In general, CK2 is a heterotetramer consisting of two catalytic α or 
α’ subunits and two regulatory β subunits, and is specifically inhibited 




SYK belongs to the tyrosine protein kinase family, SYK/ZAP70 
subfamily and plays a critical role in signalling through immune 
receptors, namely in B-cell antigen receptor (BCR) stimulated 
responses or in phosphoinositide 3-kinase (PI3K) dependent natural 





SYK phosphorylates tyrosine residues followed by two amino acid 
residues with side chains negatively charged (Tyr – Asp/Glu – 
Asp/Glu). 
Structurally, SYK comprises two N-terminal regulatory Src-
homology 2 (SH2) domains followed by a catalytic region. (Arias-




LMTK2 (Lemur Tyrosine Kinase 2, also known as KPI-2 for Kinase/ 
Phosphatase/ Inhibitor-2) is a 1503-residue protein with two predicted 
transmembrane helices at the N terminus, a kinase domain, followed 
by a C-terminal domain. It has been described to associate with PP1C 
and Inh2 to form a regulatory complex that is localized at membranes. 
(Wang and Brautigan, 2002) 
LMTK2 is strictly a Ser/Thr kinase that reacts with Ser either 
preceded by or followed by Pro residues but unlike other Pro-directed 
kinases does not strictly require an adjacent Pro residue. To this date, 
LMTK2 has been only shown to phosphorylate CFTR and and directly 
bind to myosin VI, an actin-based retrograde motor protein that is 
known to facilitate CFTR endocytosis. (Wang and Brautigan, 2006) 
















CFTR regulation is highly dependent on phosphorylation and 
dephosphorylation by different kinases and phosphatases. However, 
novel kinases that interact with CFTR have been described and it is 
necessary to better understand those protein-protein interactions, in 
order to have a wider perspective of CFTR regulation and ultimately 
CF pathophysiology. 
Therefore, in the main objective of the present work was to study 
the effect of AMPK, CK2 and SYK phosphorylation upon CFTR 
function. 
For that we proposed:  
a) To study the mechanism by which genotypic alterations in the 
CFTR gene enhance the predisposition to develop pancreatitis and its 
relation with AMPK phosphorylation;  
b) To characterize the effect of CK2 and SYK phosphorylation 
upon CFTR biogenesis, trafficking and function, namely by studying 
the effect of mutating putative phosphorylation sites for these kinases. 
Altogether, we expected to contribute to novel insights into CFTR 
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Chapter II – Methods and Materials 
 
1. Production of CFTR variants 
 
1.1 Characterization of the Biological material 
 
1.1.1 Bacterial strain 
 
The bacterial strain used for DNA cloning and amplification was 
XL1-Blue (Stratagene, La Jolla, CA, USA). These Escherichia coli 
(E.coli) cells have tetracyclin and cloranfenicol resistance and exhibit 
the Hte phenotype, which increases the transformation efficiency of 
ligated and large DNA molecules. XL1-Blue cells are deficient in all 
known restriction systems [Δ(mcrA)183 Δ(mcrCB-hsdSMR-mrr)173]. 
The strain is endonuclease deficient (endA), greatly improving the 
quality of miniprep DNA, and recombination deficient (recA), helping to 
ensure insert stability. The lacIqZDM15 gene on the F´ episome allows 
blue-white screening for recombinant plasmids. 
 
Genotype: Tetr∆(mcrA)183 ∆(mcrCB-hsdSMR-mrr)173 endA1 supE44 
thi-1 recA1 gyrA96 relA1 lac Hte [F´ proAB lacIqZ∆M15 Tn10 (Tetr) 
Amy Camr]. 
 
1.1.2 Plasmid vectors 
 
wt-CFTR and F508del -CFTR were introduced into pBluescript 
vector (Appendix I) by ligation into Sma I restriction site. All the other 





1.2 Competent Bacteria – Production and 
Transformation 
 
1.2.1 Production of competent bacteria 
 
Bacteria were plated in LB-agar medium and a single colony was 
used to inoculate a small volume of LB medium overnight at 37°C with 
vigorous shaking (220 rpm). This pre-inoculum was then used to 
inoculate a larger volume of LB medium, typically 100 ml, which was 
also grown at 37°C (220 rpm) to final concentration of 5 x 107 
bacteria/mL (corresponding to an OD of 0.3 at 600 nm). Bacteria were 
transfered to ice and pelleted by centrifugation (1000 g for 15 min at 
4°C). The bacterial pellet was then resuspended, incubated on ice for 
15 min in RF1 buffer (100 mM RbCI, 50 mM Mn(OH)2, 30 mM 
KCH3COO, 10 mM Ca(OH)2, pH 7.5, 15 % (w/v) glycerol, pH 5.8; all 
from Sigma-Aldrich, St. Louis, MO, USA)  - 1/3 of initial volume - and 
re-pelleted by centrifugation (1000 g for 15 min at 4°C). This second 
pellet was resuspended and incubated on ice for 15 min in RF2 buffer 
(10 mM RbCI, 75 mM Ca(OH)2,, 10 mM MOPS, 15 % (w/v) glycerol, 
pH 6.5; all from Sigma-Aldrich) – 1/12 of initial volume. 200 μl aliquots 
were then rapidly frozen with liquid nitrogen and stored at -80°C.  
 
1.2.2 Transformation of competent bacteria 
 
Bacteria were transformed by incubating a 200 μL aliquot of 
competent cells with DNA (~100 ng of ligation products or ~1 ng of 
purified plasmids) for 30 min on ice, performing a heat-shock (90 s at 
42°C), further incubating the mixture for 2 min on ice and then allowing 
antibiotic resistance to be expressed by growth in antibiotic-free LB 
medium for 45 min at 37°C at 220 rpm. Bacteria were then pelleted 
(5000 g for 2 min), the supernatant was discarded and the pellet was 
resuspended in the remaining supernatant medium. This suspension 
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was then plated into LB-agar supplemented with the appropriate 
antibiotic (100 μg/mL ampicillin, Sigma-Aldrich, for pNUT and 
pBluescript) and left to grow overnight.  
Transformed bacterial colonies were grown in LB medium 
supplemented with the appropriate antibiotic and used to extract 
plasmid DNA, which was screened by automatic DNA sequencing. 
After screening, positive clones were stored in liquid LB medium 
supplemented with 15 % (w/v) glycerol (Sigma-Aldrich) at - 80°C.  
 
1.3 DNA Extraction 
 
Small scale plasmid DNA was purified with commercial kit 
JETQUICK Plasmid Miniprep Spin Kit (Genomed, Lohne, Germany). 
This protocol is based on an alkaline lysis of the bacteria in the 
presence of SDS, to denature bacterial proteins, followed by a 
centrifugation step to remove cellular debris, genomic DNA and 
denatured proteins and adsorption of the plasmid DNA in the 
supernatant to an anionic exchange matrix in the presence of high 
saline concentrations. After adsorption, the DNA is washed and eluted 
in water or TE buffer (10mM Tris/HCl, pH8).  
DNA concentration was determined by measurement of the 
absorbance at 260 nm (one absorbance unit corresponding to 50 
μg/mL of dsDNA) and its purity was evaluated by assessment of the 
ratio A260/A280. 
 
1.4  Mutagenesis 
 
Point mutations were introduced into pBluescript wt-CFTR, using a 
combination of the QuickChange® Site-Directed Mutagenesis Kit 
(Stratagene) and the KOD Hot Start Kit (Novagene, Darmstadt, 




purified mutagenic primers (Thermo Electron Corporation, Waltham, 
MA, USA). 
The amplification was confirmed by agarose gel electrophoresis 
and the resultant mutant plasmid was hydrolised with DpnI (Invitrogen, 
Carlsbad, CA, USA), a restriction enzyme that specifically hydrolyzes 
methylated and hemi-methylated DNA, thus removing all parental 
bacterial DNA.  
After bacterial transformation (section II-1.2.2) and plasmid DNA 
extraction (section II-1.3), the presence of each mutation was verified 
by automatic DNA sequencing (section II-1.5). 
Sense primers used in the mutagenesis reactions are presented in 
the Table 1.1. For each sense primer a complementary anti-sense 
primer was also used. 
 
Table 1.4.1: Sense primers for mutagenesis reaction. 
Name  Sequence 
S422A s  5’- CAATAACAATAGAAAAACTGCTAATGGTGATGACAGCC -3’ 
S422D s  5’- CAATAGAAAAACTGATAATGGTGATGAC -3’ 
Y512A s  5’-CATCTTTGGTGTTTCCGCTGATGAATATAGATACAGAAGCGTC-3’ 
Y512D s  5’-CGCTTCTGTATCTATATTCATCATCGGAAACACCAAAGATG-3’ 
Y512F s  5'-CATCTTTGGTGTTTCCTTTGATGAATATAGATACAGAAGCGTC-3’ 
F508del Y512A s  5’-CGGTGTTTCCGCTGATGAATATAGATACAGAAGCGTCATC-3’ 
F508del Y512D s  5’-CATCGGTGTTTCCGATGATGAATATAGATACAGAGCG-3’ 
F508del Y512F s  5'-CATTGGTGTTTCCTTTGATGAATATAGATACAGAAGCGTC-3’ 
S573A s  5´-GCTGATTTGTATCTTCTAGACGCTCCTTTTGG-3’ 
S573C s  5´-GCTGATTTGTATCTTCTAGACTGTCCTTTTGGATAC-3’ 
T1471A s  5’-GCTGCTCTGAAAGAGGAGGCAGAAGAAGAGGTGCAAG-3’ 
T1471D s  5’-CTGCTCTGAAAGAGGAGGACGAAGAAGAGGTGCAAG-3’ 
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1.5  DNA Sequencing  
 
Plasmid DNAs were purified with the JETquick Plasmid Miniprep 
(Genomed), as described. (section II-1.3). The sequencing reactions 
were performed using the ABI Prism BigDye Terminator Cycle 
Sequencing Kit (Applied Biosystems, Foster City, CA, USA) according 
to the manufacturer’s instructions. The products were analyzed in the 
automatic sequencer 3130 XL Genetic Analyzer (Applied Biosystems).   
Normally, only forward primers were used in the sequencing 
reactions. The following table summarizes the primers used in the 
sequencing reactions (Table 1.2). 
 




position in CFTR 
mRNA 
CF-5'NC-f 5’- GCA TTA GGA GCT TGA GCC CA -3’   72-96 
CF Ex5.F 5’- CTC CTT TCC AAC AAC CTG AAC -3’ 679-699   
B3R 5’- AAT GTA ACA GCC TTC TGG GAG -3’   1318-1338 
C2R 5’- AGC AGT ATA CAA AGA TGC TG -3’   1812-1831 
D1R 5’- GAC AAC AGC ATC CAC ACG AA -3’   2490-2509 
E1R 5’- AGA TTC TCC AAA GAT ATA GC  -3’   3055-3074 
Ex18.F 5’- AAC TCC AGC ATA GAT GTG G  -3’   3574-3592 
Ex 22.F 5’- AGC AGT TGA TGT GCT TGG C -3’   4184-4202 
 
For sequence analysis, the sequences obtained were analysed 
through comparison with the reference CFTR sequence (Genebank 
accession number: M26886). This comparative analysis was done 
using the softwares ChromasPro (http://www.technelysium.com.au) 






2 Biochemical and functional assays of 
CFTR variants 
 
2.1 Characterization, Culture and Maintenance 
of cell lines 
 
The BHK 21 (Baby Hamster Kidney) cell line is a quasi-diploid 
established line of variant hamster cells, descendent from a clone of 
an unusually rapidly growing primary culture of new-born hamster 
kidney tissue (Stoker and Macpherson, 1964). BHK cells are usually 
described as fibroblasts and are widely used in cell physiology and 
biochemistry studies, being easy to grow and transfect.  
BHK mutants (BHK wt-CFTR and F508del-CFTR) used in this 
study were obtained by stable transfection with pNUT wt-CFTR or 
pNUT F508del-CFTR respectively.  
BHK cells were cultured in a 1:1 mixture of Dulbecco’s Modified 
Eagle Medium (DMEM) and Ham’s F-12 nutrient medium 
supplemented with 5 % (v/v) fetal calf serum, 100 U/mL penicillin and 
100 mg/mL streptomycin (all from Invitrogen). The medium used with 
stable transfected cells also contained 500 µM methotrexate (MTX)  
(AAH Pharmaceuticals Ltd., Coventry, UK).  
Calu-3 (cancer lung 3) and CFBE (cystic fibrosis human bronchial 
epithelial) cells stably transfected with wt-CFTR (CFBE-wt) and 
F508del-CFTR (CFBE-F508del) were cultured in Minimum Essential 
Media (MEM), containing 10 % (v/v) fetal calf serum, 100 U/mL 
penicillin and 100 mg/mL streptomycin (all from Invitrogen). 
HeLa (Henrietta Lacks cervical cancer) cells were cultured in RPMI 
medium 1640 with 10 % (v/v) fetal calf serum, 100 U/mL penicillin and 
100 mg/mL streptomycin (all from Invitrogen). 
Continuous growth was permitted by pre-confluence enzymatic 
dissociation with trypsin (Invitrogen), an enzyme that hydrolyzes 
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proteins in the extracellular matrix. After dissociation, cells were 
resuspended and redistributed in new flasks or plates. Cell lines were 
stored in aliquots of cells frozen in 90 % (v/v) FCS (Invitrogen) and 
10 % (v/v) DMSO (Sigma-Aldrich), a cryoprotectant that prevents the 
formation of ice crystals during the freezing process.  
Cultures were maintained at 37°C in a humidified atmosphere of 
5% (v/v) CO2.  
 
2.2 Transfection using cationic lipossomes 
 
BHK cells were transfected with 2 μg of plasmid DNA using the 
Lipofectin® reagent (Invitrogen), a cationic liposome formulation that 
forms DNA complexes able to fuse with the cell membrane. Selection 
for stable transfectants is achieved by adding the selective reagent 
MTX (500 µM) to the culture medium 48 h after transfection. Individual 
clones were isolated at 10-15 days in the selection medium. BHK 





´ Total RNA was isolated using the RNeasy extraction kit (Qiagen, 
Hilden, Germany) according to the manufacturer's instructions. Total 
RNA concentration was determined by measurement of A260 and was 
treated with 1 U of RNAse-free DNAse I (Invitrogen) for 1h min at 37ºC 
to eliminate contamination with genomic DNA. RNA was annealed to 
100 pmol of random hexamers (Invitrogen) and the mixture was 
incubated 10 min at 60°C and then chilled on ice. Following the 
addition of 5x first strand buffer (250 mM Tris-HCI pH 8.3, 375 mM KCI, 
15 mM MgCI2) (Invitrogen), 0.01 M DTT (Invitrogen), 2.5 mM dNTP 




(Invitrogen), the mixture was incubated 2 min at 42°C. SuperScript II 
RNaseH- reverse transcriptase (200 U; Invitrogen) was added and the 
final mixture for incubated 60 min at 42°C. The reaction was stopped 
by heating at 70°C for 15 min. The PCR amplification of the cDNA 
products was carried out in a reaction that contained 5 μL of cDNA, 
PCR buffer (100 mM Tris-HCI pH 8.3, 500 mM KCL, 15 mM MgCl2, 
0.01 % (w/v) gelatin) (Perkin Elmer, Norwalk, CT, USA), 25 mM dNTP 
mix (Amersham), 10 pmol of each primer and 1 U Taq polymerase 
(Perkin Elmer) or 1.5 U Pfu turbo polymerase (Stratagene). 
To amplify cDNA, human LMTK2 primers amplifying a 239 bp 
fragment were used: forward primer 5’-TTGAGCACCTCATTGCAGTC-
3 (2700-2719 of human LMTK2) and reverse primer,  5’-
CTGTTATCCAGGCTGTGGGT-3’ (2919-2938 of human LMTK2) 
 
2.4 Iodide efflux assays 
 
CFTR-mediated iodide efflux was measured at room temperature, 
as described (Lansdell et al., 1998). BHK cells grown to confluence on 
60 mm dishes were incubated for 1h in iodide loading buffer (136 mM 
NaI, 3mM KNO3, 2mM Ca(NO3)2, 11 mM glucose, 20 mm HEPES, pH 
7.4-7.5; all from Sigma-Aldrich) and then thoroughly washed with efflux 
buffer (136 mM NaNO3, 3mM KNO3, 2mM Ca(NO3)2, 11 mM glucose, 
20 mm HEPES, pH 7.4-7.5; all from Sigma-Aldrich). Efflux buffer 
aliquots were then added to the cells, left to equilibrate for 1 min, and 
collected for the iodide measurements. The first 4 aliquots were used 
to establish a baseline of iodide efflux, without CFTR simulation. CFTR 
was then stimulated with the cAMP agonist Forskolin 10 µM (Sigma-
Aldrich) and with the CFTR potentiator genistein 50 µM (Sigma-
Aldrich), for 4 minutes. Stimulation was absent in the remainder of the 
assay. The amount of iodide in each aliquot was measured with an 
iodide-selective electrode (MP225, Mettler Toledo, Thermo Electron 
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Corporation). Standard iodide solutions were also prepared freshly for 
electrode calibration and iodide concentration calculations. Date are 
expressed as mean ± SEM (standard error of the mean) of n 
observations. Statistical analyses were performed using Student’s 
unpaired t-test and a value of p < 0.05 was considered statistically 
significant. 
 
2.5 Double electrode voltage clamp 
experiments 
 
2.5.1 Isolation of the oocytes 
 
To isolate stage V-VI oocytes from Xenopus laevis mature female 
frogs (Xenopus Express, South Africa and Kaehler, Germany), the frog 
was anesthetized by immersion in 1 g/L 3-aminobenzoic acid ethyl 
ester for 30 min. The animal was placed on ice and a 1 cm incision 
was made on the abdominal wall (skin and muscle layer) 
approximately 1 cm over the hip. Ovarian lobes containing oocytes 
wrapped in connective tissue and blood vessels were removed with a 
pincet and the oocytes collected in OR-2 buffer (82.5 mM NaCl, 2 mM 
KCl, 1 mM MgCl2.6H2O, 5 mM HEPES, pH 7.4 – 7.5, all from Sigma-
Aldrich). After removal of the ovarian lobe, the incisions were sutured 
closed with sterile needles. To remove the follicular cell layers and 
connective tissue, the oocytes were then incubated with 1.11 U/mL 
Collagenase A (Clostridium histolyticum, Clostridiopeptidase A, EC 
3.3.24.3, Lypophilisate, Boehringer), for 1h at 18ºC. Defolliculated 
oocytes were washed 10 times with ND 96 buffer (96 mM NaCl, 2 mM 
KCl, 1.8 mM CaCl2.2H2O, 1 mM MgCl2.6H2O, 5 mM HEPES, 2.5 mM 
Na-Pyruvat, pH 7.4-7.5, all from Sigma-Aldrich) and placed in ND 97 




CaCl2.2H2O, 1 mM MgCl2.6H2O, 5 mM HEPES, 2.5 mM Na-Pyruvat, 
0.5 mM Theophylin, 50 mg/ mL Gentamycin, pH 7.4-7.5, all from 
Sigma-Aldrich). 
 
2.5.2 cRNA injection and voltage clamp 
 
Double-electrode voltage clamp experiments were done was 
previously described. (Kongsuphol et al., 2009). Oocytes were injected 
with cRNA (10 ng, 47 nL of double-distilled water). Water-injected 
oocytes served as controls.  2–4 days after injection, oocytes were 
impaled with two electrodes (Clark Instruments Ltd., Salisbury, UK), 
which had a resistance of <1 MΩ when filled with 2.7 M KCl. Using two 
bath electrodes and a virtual-ground head stage, the voltage drop 
across the serial resistance was effectively zero. Membrane currents 
were measured by voltage clamping (oocyte clamp amplifier, Warner 
Instruments LLC, Hamden CT) in intervals from –60 to +40 mV, in 
steps of 10 mV, each 1 s. The bath was continuously perfused at a 
rate of 5 mL/min. All experiments were conducted at room temperature 





= , which 
derives from Ohm’s law. Data are expressed as mean ± SEM 
(standard error of the mean) of n observations. Statistical analyses 
were performed using Student’s unpaired t-test and a value of p < 0.05 
was considered statistically significant. These experiments were 

























Chapter III – Results  
 
1. Metformin increases the risk for 
pancreatitis in diabetes patients bearing 
the CFTR variant S573C 
 
Phosphorylation is the major mechanism that regulates CFTR 
function as a Cl- channel. Several kinases phosphorylate and activate 
CFTR such as PKA, PKC, PKG and AMPK. (Faria et al., 2009) 
(Hallows et al., 2000;Hallows et al., 2003) 
AMP-activated protein kinase (AMPK) is a Ser/Thr kinase, 
activated upon ATP depletion. AMPK stimulates catabolic pathways 
that ultimately lead to ATP production and down-regulates anabolic 
pathways that consume ATP. (Hallows et al., 2000;Hallows et al., 
2003) 
Metformin is a biguanidine compound used in the clinical treatment 
of type II diabetes, and it is described to activate AMPK, which co-
localizes with CFTR and attenuates its function, through the inhibition 
of Complex I of the respiratory chain. In clinical use, it replaced 
phenformin which had higher incidence of lactic acidosis. (Hawley et 
al., 2002) (Kongsuphol et al., 2009) 
Nonetheless, metformin still increases the risks of lactic acidosis 
and patients using this compound tend do develop pancreatitis 
secondary to metformin poisoning (or at therapeutic metformin doses, 
in the case of renal failure). (Mallick, 2004) 
The pancreas contains exocrine tissue that produces several 
digestive enzymes that enter the small intestine through the pancreatic 
duct. These enzymes are delivered in an alkaline, bicarbonate-rich 
fluid that neutralizes the acidic chime. Bicarbonate secretion by the 




role is still controversial, namely whether bicrbonate is directly 
transported by CFTR or by a transporter (SLC26A) which in turn is 
regulated by CFTR. (Steward et al., 2005) 
Intriguingly, patients with pancreatitis have an increased incidence 
of genotypic alterations in the CFTR gene, including the non-disease 
causing variant S573C. (Keiles and Kammesheidt, 2006) 
Therefore, we used double electrode voltage clamp (DEVC) to 
study the relation between pancreatitis and the increased genotypic 
alterations in the CFTR gene: whole cell chloride conductances were 
activated by 3-Isobutyl-1-methylxanthine (IBMX 1 mM) and forskolin 
(Forsk 2 µM) or Forsk 20 µM in Xenopus laevis oocytes expressing wt-, 




1.1 Effect of metformin upon IBMX/Forsk 
induced CFTR activation 
 
To study the effect of metformin upon CFTR activation, whole-cell 
chloride currents, in Xenopus laevis oocytes, were activated by 1mM 
BMX and 2 µM Forsk. IBMX and Forsk increase whole-cell chloride 
current in Xenopus laevis oocytes expressing CFTR by augmenting 
the intracellular cAMP level and, consequently, activating PKA. IBMX 
inhibits cAMP and cGMP phosphodiesterases, while Forsk activates 
adenylate cyclase.  
Whole cell conductance (Gm) was 4,5 ± 1,0 µS in non-stimulated 
oocytes expressing wt-CFTR and 110,0 ± 15,3 µS after IBMX and 
Forsk activation. In oocytes expressing S573C-CFTR, IBMX and Forsk 
induced a Gm of 78,1 ± 7,3 µS, while non-stimulated Gm was 2,7 ± 0,8 
µS (Figure III.1) 
Metformin (Met, 2 mM) and phenformin (Phen, 5 mM) incubation 
significantly reduced IBMX/Forsk Gm in S573C-CFTR expressing 
oocytes, respectively to 57,7 ± 7,3 µS and 47,7 ± 6,7 µS. Incubation 
with compound C (CC 1 mM), an AMPK inhibitor, augmented Gm to 
107,6 ± 12,5 µS: this effect was not statistically significant though. 
(Figure III.1) 
In wt-CFTR expressing oocytes, only Phen significantly reduced 
Gm, which was down to 61,5 ± 11,6 µS. On the other hand, Met only 
reduced Gm to 94,8 ± 11,6 µS. CC significantly augmented whole cell 
IBMX/Forsk current, as expected. (Figure III.1) 
Interestingly, wt- and S573C-CFTR IBMX/Forsk activated Gm are 
significantly different, in the presence of Met 2 mM, suggesting that the 







Figure III.1 – Effect of metformin upon IBMX/Forsk CFTR activation. 
Whole cell chloride conductances activated by 3-Isobutyl-1-methylxanthine 
(IBMX 1 mM) and Forskolin (Forsk 2 µM) in Xenopus laevis oocytes 
expressing wt-CFTR or S573C-CFTR. When activated, oocytes expressing 
S573C-CFTR show lower whole cell conductance which is significantly 
inhibited by metformin (Met 2mM). * indicates statistical significant difference 
when compared with IBMX/Forsk activated chloride current. All data is 
presented as mean ± SEM. The number between brackets represents the 
number of experiments. 
 
1.2 Effect of metformin on low CFTR activation 
 
To further analyse the effects of metformin upon CFTR, whole cell 
chloride currents were activated only by Forsk 20 µM, in order to mimic 
physiological CFTR activation. 
We also studied the effect of the substitution of the serine at the 
position 573 by an alanine (S573A) in Gm and the metformin sensitivity 
for the CFTR variants produced. 
Upon these experimental conditions Met 500 µM significantly 
reduced Gm in S573C-CFTR expressing oocytes. However, there was 









Figure III.2– Effect of metformin upon low CFTR activation. Whole cell 
conductances were activated by Forsk 20 µM in Xenopus laevis oocytes 
expressing wt-, S573A or S573C-CFTR. There is a significant inhibition of 
whole cell chloride conductance by Met 500 µM in oocytes expressing 
S573C-CFTR. * and # indicate statistical significant difference when 
compared with control (ND 96) and IBMX/Forsk activated chloride current, 
respectively. All data is presented as mean ±SEM. The number between 
brackets represents the number of experiments. 
 
Metformin 500 µM significantly reduces relative CFTR conductance 
for S573C-CFTR and S573A-CFTR but has a mild effect upon wt-
CFTR. (Figure III.3). 
Altogether, these data suggest thatS573C-CFTR is less functional 
and more sensitive towards metformin than wt- and S573A-CFTR, at 
low physiological activation. 
 




























Figure III.3 – Effect of metformin upon relative CFTR conductance. Whole 
cell conductances were activated by Forsk 20 µM in Xenopus laevis oocytes 
expressing wt-, S573A or S573C-CFTR.  
 
1.3 Extracellular acidic pH upon CFTR 
activation 
 
The effect of changes in the luminal and cytoplasmic pH on CFTR 
has been a matter of great interest for several CF research groups. 
This topic is highly significant since CFTR channels are expressed in 
membranes that may experience pH environments ranging from the 
extremely acid compartments such as endosomes to the basic lumen 
of pancreatic ducts. (Reddy et al., 1998) 
Previous studies have shown that changing luminal pH between 
5.0 and 8.5 had no effect on activated or non activated CFTR Gm, 
using sweat glands from adult male volunteers in Ussing Chamber 
experiments. (Reddy et al., 1998) 
Nevertheless, using a different cell model, we assessed the effect 





















Figure III.4 – Extracellular acidic pH upon wt-CFTR activation: 
Representative original recordings (A and B) and summary of (C) of whole cell 
chloride conductance activated by Forsk 20 µM in Xenopus laevis oocytes 
expressing wt-CFTR. Extracellular pH 5.5 increased Gm. (A and C). This effect 
was abolished in the absence of Cl-, which was replaced with gluconate. (B 
and C) * and # indicate statistical significant difference when compared with 
control (ND 96) and Forsk activated current, respectively. All data is 
presented as mean ±SEM. [Data obtained in collaboration with Patthara 
Kongsuphol and included here with permission] 
 
As previously described by Reddy et al, extracellular alkaline pH 
had no effect upon CFTR Gm (data not shown). However, interestingly, 
acidic pH augmented CFTR Gm in Xenopus laevis oocytes expressing 
wt-CFTR. This effect was abolished in the absence of Cl- (replaced by 
gluconate), suggesting that the extracellular acidic pH had a direct 

































Figure III.5 – Extracellular acidic pH upon S573A-CFTR activation: 
Representative original recordings (A and B) and summary of (C) of whole cell 
chloride conductance activated by Forsk 20 µM in Xenopus laevis oocytes 
expressing S573A-CFTR. Extracellular pH 5.5 increased Gm slightly (A and C). 
This effect was abolished in the absence of Cl-, which was replaced with 
gluconate. (B and C). * and # indicate statistical significant difference when 
compared with control (ND 96) and Forsk activated current, respectively. All 
data is presented as mean ±SEM. [Data obtained in collaboration with 
Patthara Kongsuphol and included here with permission] 
 
 
Extracellular pH 5.5 also augmented S573A-CFTR Forsk-
activated current but had a rather modest effect upon S573C-CFTR Gm. 
(Figures III.5 and III.6) 
In order to confirm whether this differential extracellular acidic 
pH effect upon CFTR function as a Cl- channel was not an internal 
property of the oocytes, and thus an artifact, non-injected oocytes were 
used as a control. (Figure III.7) 
Altogether, these experiments suggest that acidic pH may have 



























Figure III.6 – Extracellular acidic pH upon S573C-CFTR activation: 
Representative original recordings (A and B) and summary of (C) of whole cell 
chloride conductance activated by Forsk 20 µM in Xenopus laevis oocytes 
expressing S573C-CFTR. Extracellular pH 5.5 had a mild effect in Gm. (A and 
C). This effect was abolished in the absence of Cl-, which was replaced with 
gluconate. (B and C). * and # indicate statistical significant difference when 
compared with control (ND 96) and Forsk activated current, respectively. All 
data is presented as mean ±SEM. [Data obtained in collaboration with 



















Figure III.7 – Extracellular acidic pH upon non-injected oocytes: 
Representative original recordings (A and B) and summary of (C) of whole cell 
chloride conductance activated by Forsk 20 µM in non-injected Xenopus 
laevis oocytes. Extracellular pH 5.5 had no effect in Gm. All data is presented 
as mean ±SEM. [Data obtained in collaboration with Patthara Kongsuphol and 
included here with permission] 
 
1.4 Intracellular pH upon CFTR activation 
 
Using 1 mM CCCP (Carbonyl cyanide m-chloro phenyl hidrazone), 
a protonphore that uncouples the respiratory chain, we studied the 
effects of intracellular pH upon CFTR Gm. Briefly, CCCP act as a ion 
carrier binding to H+, shielding its charge from the surrounding 
environment, and thus facilitating its crossing through the plasma 
membrane. 
After maximal CFTR activation with Forsk 20 µM at physiological 
pH, intracellular pH was changed sequentially from 5.5 to 8.5. 
As expected, and previously described in sweat glands (Reddy et al., 
1998) changes in the cytoplasmic pH had significant effect on 
cAMP/ATP-activated wt-CFTR Gm: acidic pH was found to inhibit while 
alkaline pH enhanced CFTR Gm. (Figure III.8) 
A 10% increase in CFTR Gm can be seen in both S573A- and 






Figure III.8 – Intracellular pH upon wt-CFTR activation: Representative 
original recording (A) and summary of (B) of whole cell chloride conductance 
activated by Forsk 20 µM in Xenopus laevis oocytes expressing wt-CFTR. 
Acidic intracellular pH inhibited while alkaline intracellular pH enhanced CFTR 
Gm *, a, b, c, and d indicate statistical significant difference when compared 
with control (ND 96 and CCCP), pH 5.5, pH 6.5, pH 7.5 and pH 8.5, 
respectively. All data is presented as mean ±SEM. [Data obtained in 
collaboration with Patthara Kongsuphol and included here with permission] 
 
  
Figure III.9 – Intracellular pH upon S573A-CFTR activation: 
Representative original recording (A) and summary of (B) of whole cell 
chloride conductance activated by Forsk 20 µM in Xenopus laevis oocytes 
expressing S573A-CFTR. Acidic intracellular pH significantly inhibited CFTR 
Gm. Alkaline intracellular pH augmented CFTR Cl- currents. *, a, b, c, and d 
indicate statistical significant difference when compared with control (ND 96 
and CCCP), pH 5.5, pH 6.5, pH 7.5 and pH 8.5, respectively. All data is 
presented as mean ±SEM. [Data obtained in collaboration with Patthara 








Figure III.10 – Intracellular pH upon S573C-CFTR activation: 
Representative original recording (A) and summary of (B) of whole cell 
chloride conductance activated by Forsk 20 µM in Xenopus laevis oocytes 
expressing S573C-CFTR. Sequential change in intracellular pH from 5.5 to 
8.5 increased CFTR Gm. *, a, b, c, and d indicate statistical significant 
difference when compared with control (ND 96 and CCCP), pH 5.5, pH 6.5, 
pH 7.5 and pH 8.5, respectively. All data is presented as mean ±SEM. [Data 
obtained in collaboration with Patthara Kongsuphol and included here with 
permission] 
 
Intracellular pH 5.5 led to approximately 25% Gm inhibition in 
S573A-CFTR, 20% Gm inhibition in S573C-CFTR and 10% inhibition in 
wt-CFTR. (Figure III.11) 
At low intracellular pH CFTR phosphorylation by PKA is inhibited, 
resulting thus in a decrease in Gm. PKA is found to have optimal 
catalytic effect around neutral pH. Nevertheless, low pH can also be 
responsible for conformational changes in CFTR or ATP ionization 
state, which would also reduce PKA affinity for CFTR. (Reddy et al., 
1998) 
Exposure to alkaline intracellular pH irreversibly inhibits CFTR 
dephosphorylation either by denaturing phosphatases or by inducing 
conformational changes in CFTR which renders it a less effective 
substrate for these endogenous phosphatases. (Reddy et al., 1998) 
Altogether, these results show that changes in intracellular pH 





Our results suggest that non-CF patients carrying the S573C 
mutation in one CFTR allele may have a higher risk of developing 
pancreatitis when treated with metformin because this variant is less 
functional than wt-CFTR and more sensitive to AMPK phosphorylation 
- which results in a significant decrease in Gm.  
Moreover, intracellular pH regulates S573C- and S573A-CFTR 
function in a way that differs from wt-CFTR, suggesting that this serine 
residue, located at the CFTR NBD1, may play a very important role in 































Figure III.11 – Intracellular pH upon relative CFTR activation: Whole cell 
chloride conductance activated by Forsk 20 µM in Xenopus laevis oocytes 
expressing wt-, S573A or S573C-CFTR. [Data obtained in collaboration with 




2.  Analysis of the role of Casein Kinase II in 
CFTR function 
 
Recently, CK2 has been considered a kinase with a hypothetical 
role in CFTR biogenesis, trafficking and function with several 
phosphorylation sites described. (Pagano et al., 2008) (Ostedgaard et 
al., 2006). 
Pagano et al found that CK2 in vitro phosphorylates CFTR NBD1 
at S422 and not at S511. (Pagano et al., 2008)  
Moreover, T1471, a residue in close proximity to CFTR C-terminus, 
was described as an hypothetical CK2 phosphorylation site. 
(Ostedgaard et al., 2006). 
To study the effect of CFTR phosphorylation by CK2, the three 
putative CK2 phosphorylation residues were mutated by site-directed 
mutagenesis either to a neutral residue - alanine (A) or to an acidic 
residue - aspartate (D). Despite not being phosphorylatable, those 
residues mimic the non-phosphorylated or phosphorylated state, 
respectively. 
To elucidate the role of these sites in CFTR function, both iodide 
efflux and DEVC experiments were done. 
 
2.1 Functional analysis of S422A/D-CFTR 
 
Firstly, we assessed the effect of TBB (4,5,6,7-
tetrabromobenzotriazole), a CK2 inhibitor, upon CFTR function using 
DEVC. (Figure III.12) 
TBB was found to decrease processing of wt-CFTR and to 
increase the turnover rate of its immature form. However, TBB caused 
no effect upon F508del-CFTR turnover nor did it cause this mutant to 




TBB significantly reduces CFTR Gm in Xenopus laevis oocytes 
expressing wt-CFTR. Moreover, TBB does not have any impact upon 





























Figure III.12 –Functional Analysis of S422A/D-CFTR: Summary of whole 
cell chloride conductances (A and B) and relative CFTR conductance (C) 
activated by IBMX 1mM and Forsk 2 µM in Xenopus laevis oocytes 
expressing wt-, S422A-, S422D-, F508del- or F508del-S422A-CFTR. Mutating 
S422 to an alanine or aspartate significantly reduces or augments wt-CFTR 
Gm, respectively. Both, S422A-CFTR and S422D-CFTR are significantly 
inhibited by TBB, suggesting that this not the only residue which is 
phosphoylated by CK2. # and *.indicate statistical significant difference when 
compared with control (ND96) and activated Gm and respectively. + indicates 
statistical significant difference when compared with activated wt-CFTR Gm. 
All data is presented as mean ±SEM. [Data obtained in collaboration with 



























































































































Figure III.13 – Iodide efflux from BHK cells expressing S422D-CFTR: 
Time course (A) and summary (B) of iodide efflux from BHK cells expressing 
wt-, F508del- or S422D-CFTR. Forsk 10 µM and genistein 50 µM stimulated 
CFTR in the period [0;4] min. S422D-CFTR seems to be less functional than 
wt-CFTR, in BHK cells. # indicates statistical significant difference when 
compared with F508del- iodide efflux. All data is presented as mean ±SEM.  
 
Mutating the S422 to an alanine decreases wt-CFTR Gm However, 
S422A has no effect upon F508del-CFTR Gm (Figure III.12) 
On the other hand, when this serine is mutated to a negative 
residue, an aspartate, Gm is significantly increased. Interestingly, these 
currents are still inhibited by TBB 10 µM, indicating that this residue is 
not the only amino acid residue phosphorylated by CK2. (Figure III.12) 
We also assessed CFTR function as a Cl- channel in BHK cells 
stably expressing wt-, F508del or S422D–CFTR by the iodide efflux 
technique. In this cell line, S422D-CFTR was found to be significantly 
less functional than wt-CFTR (Figure III.13). However, this technique is 
not as sensitive as DEVC, but on the other hand regulation of CFTR 
expression, processing and function in oocytes is completely different 
from mammalian cells. So, distinct protein mediators may also explain 
the observed differences between the two systems. 
Altogether, these data suggest that mutating S422 either into an 








































a Cl- channel. Moreover, TBB inhibition suggests that if this residue is 
phosphorylated by CK2 it is not unique.  
2.2 Functional analysis of T471A/D-CFTR 
 
The same approaches were used to mutate CK2 putative site at 
threonine residue 1471, as this had been previously described as a 
putative CK2-phosphosite [Ostedgaard et al, 2006]. Mutating T1471 
either to an alanine or an aspartate, significantly reduces both wt-
CFTR Gm and iodide efflux. (Figures III.14 and III.15). Interestingly, 
T1471A-CFTR is fully processed (Luz, 2008), suggesting that this 
mutation causes an impairment in channel gating. On the other hand, 
T1471D-CFTR is not processed into a mature form (Luz, 2008), 
implying that there might be higher turnover and/or increased 
endocytosis for this protein, since this mutant is functional when at the 
plasma membrane. (Figure III.14). As for S422, the negative charge 
(D) seems to enhance CFTR Gm, probably by mimicking the phosphate 
group, restoring Gm to a value closer to the wt-CFTR. Both T1471A- 
and T1471D-CFTR currents are still inhibited by TBB, which leads to 
the same conclusion observed for S422 – it this residue is 
phosphorylated by CK2 it is not unique. (Figure III.14). 
Additionally, T1471A did not affect current or TBB inhibition in the 


































Figure III.14 - Functional Analysis of T1471A//D-CFTR: Summary of whole 
cell chloride conductances (A and B) and relative CFTR conductance (C) 
activated by IBMX 1mM and Forsk 2 µM in Xenopus laevis oocytes 
expressing wt-, T1471A-, T1471D-, F508del- or F508del-T1471A-CFTR. 
Mutating T1471 to an alanine or aspartate significantly reduces wt-CFTR Gm, 
respectively. Both, T1471A-CFTR and T1471D-CFTR are significantly 
inhibited by TBB. # and *.indicate statistical significant difference when 
compared with control (ND96) and activated Gm and respectively. + indicates 
statistical significant difference when compared with activated wt-CFTR Gm. 
All data is presented as mean ±SEM. [Data obtained in collaboration with 
Patthara Kongsuphol and included here with permission] 
 
In BHK cells, both T1471A- and T1471D-CFTR show very low I- 
efflux - not significantly different from F508del-CFTR. (Figure III.15). 






























































































































Figure III.15 - Iodide efflux from BHK cells expressing T1471A/D-CFTR: 
Time course (A) and summary (B) of iodide efflux from BHK cells expressing 
wt-, F508del-, T1471A- or T1471D-CFTR Forsk 10 µM and genistein 50 µM 
stimulated CFTR in the period [0;4] min. Both T1471A and T1471D-CFTR 
seem to be as functional as F508del-CFTR, in BHK cells. # indicates 
statistical significant difference when compared with F508del iodide efflux. All 


































































2.3 Functional analysis of S511A/D-CFTR 
 
The same approaches were used for mutating CK2 putative site at 
serine residue 511.Mutating S511 either to an alanine or an aspartate 















Figure III.16 - Iodide efflux from BHK cells expressing S511/D-CFTR: 
Time course (A) and summary (B) of iodide efflux from BHK cells expressing 
wt-, F508del-, S511A- or S511D-CFTR Forsk 10 µM and genistein 50 µM 
stimulated CFTR in the period [0;4] min. Both S511A- and S511D-CFTR 
seem slightly less functional than wt-CFTR, in BHK cells. # and * indicate 
statistical significant difference when compared with F508del and wt-CFTR 
iodide efflux, respectively. All data is presented as mean ±SEM.  
 
3 Analysis of the role of the Spleen Tyrosine 
Kinase in CFTR function 
 
Spleen Tyrosine Kinase (SYK) belongs to the tyrosine protein 
kinase family and has one putative phosphorylation site in CFTR 
sequence, Y512. (Luz, 2008).  
Substitution of Y512 to an A or a D does not affect the turnover of 










































































To study the effect of CFTR phosphorylation by SYK, Y512 was 
mutated by site-directed mutagenesis to alanine (A), aspartate (D) or 
phenylalanine (F) and both iodide efflux and DEVC experiments were 
performed. 
Mutating Y512 either to an aspartate or a phenylalanine did not 
change significantly CFTR Gm. However, for Y512A, there is a 
significant increase in CFTR Gm, in both wt- and F508del background 
(2-3 fold). This mutation is probably responsible for a dramatic 
conformational perturbation in the area around this residue because A 
is both small and neutral. Such conformational change probably 
facilitates channel gating and suggests that this residue, in close 
proximity to F508del, has a role in CFTR function. When maintaining 
either charge (D) or size (F), no effect is seen, strengthening this 


















Figure III.17 - Functional Analysis of Y512A/D/F-CFTR: Summary of whole 
cell chloride conductances (A and B) activated by IBMX 1mM and Forsk 2 µM 
in Xenopus laevis oocytes expressing wt-, Y512A-, Y512D-,Y512F-, F508del- 
or F508del-Y512A-CFTR. Mutating Y512A to an alanine significantly 
increases wt- and F508del-CFTR Gm. #  indicates statistical significant 
difference when compared with control (ND96), while + indicates statistical 
significant difference when compared with activated wt-CFTR Gm. All data is 
presented as mean ±SEM. [Data obtained in collaboration with Patthara 

















































In BHK cells, Y512A-CFTR is as functional as wt-CFTR, while 
Y512D-CFTR significantly inhibits efflux iodide upon Forsk/Gen 
stimulation. However, this technique is not as sensitive as DEVC, as 














Figure III.18 - Iodide efflux from BHK cells expressing Y512A/D-CFTR: 
Time course (A) and summary (B) of iodide efflux from BHK cells expressing 
wt-, F508del, Y512A- or Y512D-CFTR Forsk 10 µM and genistein 50 µM 
stimulated CFTR in the period [0;4] min. Y512D-CFTR is less functional than 
wt-CFTR, in BHK cells. # and * indicate statistical significant difference when 
compared with F508del and wt-CFTR iodide efflux, respectively. All data is 






































































4  LMTK2 expression in human epithelial 
cells 
 
Recently, we have started to study the effect of another kinase 
upon CFTR, namely LMTK2 (Lemur Tyrosine Kinase 2), a 
transmembrane protein with kinase activity described to form 
regulatory complexes at the membrane. LMTK2 has been found to 
phosphorylate CFTR R-domain and directly bind to myosin VI, a 
protein that facilitates CFTR endocytosis. (Wang and Brautigan 2002), 
(Wang and Brautigan 2006) (Swiatecka-Urban et al, 2004).  
In preliminary results, we found that LMTK2 is expressed in human 
epithelial cells from bronchi - CFBE (stably transfected with wt- or 
F508del-CFTR), lung - Calu-3, and cervix – HeLa. (Figure III.19) 
Results obtained by Dr. Swaitecka-Urban, with whom we have 
established a collaborative effort to functionally characterize the CFTR-
LMTK2 interaction, show also that CFTR co-imunoprecipitates with 
LMTK2 and that LMTK2 silencing by siRNA renders CFTR endocytosis 
less efficient, thus increasing the membrane stability of wt-CFTR. (Dr. 
Swaitecka-Urban, personal communication) 
 
 
1              2             3              4 
 
 
Figure III.19 - RT-PCR for LMTK2 expression in human cells - 1) HeLa; 2) 
CFBE stably transfected with wt-CFTR; 3) CFBE stably transfected with 
F508del-CFTR 4) Calu-3. To amplify cDNA, human LMTK2 primers amplifying 









































































Chapter IV – Discussion and Perspectives  
 
Phosphorylation is the major mechanism that regulates CFTR 
function as an ion channel, being PKA the most studied kinase 
involved in CFTR activation. Therefore, the major aim of this work was 
to study the effects of three major kinases upon CFTR function. 
PKA phosphorylates several serines in the R domain, including: 
S660, S686, S700, S737, S768, S790, S795, S813 (Picciotto et al, 
1992). However, phosphorylation of the R domain by PKA is not 
sufficient to activate CFTR. (Kongsuphol et al, 2009) 
Individual phosphorylation at PKA sites has additive effects upon 
CFTR function. Nevertheless, S737 and S768 have been suggested to 
have an inhibitory effect upon CFTR, since their elimination largely 
increases CFTR-mediated whole-cell chloride conductance. Recently, 
it has been suggested that these sites are phosphorylated by AMPK, 
providing a mechanistic insight upon AMPK-mediated CFTR inhibition, 
previously described. (Kongsuphol et al, 2009) (Hallows et al., 
2000;Hallows et al., 2003) 
High metformin concentrations used to treat diabetes, cause 
pancreatitis in some patients and this has been related to genotypic 
alterations in the CFTR gene (Keiles and Kammesheidt, 2006). 
(Mallick, 2004). Therefore, we attempted hereto establish a functional 
relationship between these two factors, by studying the effect of 
metformin upon S573C, a non-CF variant found in patients with 
metformin-induced pancreatitis.  
Using DEVC, we found that, in the presence of metformin, S573C-
CFTR is significantly less functional than wt-CFTR, suggesting that 
metformin may indeed increase the risk for pancreatitis in patients who 




Our data also strongly suggests that S573C-CFTR regulation by 
changes in extracellular and intracellular pH is significantly different 
from that of wt-CFTR. S573C-CFTR current is strongly inhibited by 
intracellular acidic pH, which is probably responsible for inhibiting PKA 
phosphorylation and for conformational changes in CFTR or ATP 
ionization state. (Reddy et al, 1998). Altogether, these data suggest 
that the S573 residue plays an important role in ATP binding and/or 
channel gating.  
However, single-channel analysis showed that intracellular acidic 
pH stimulates CFTR activity in C127 mouse fibroblasts expressing wt-
CFTR. (Chen et al 2003). These findings suggest that CFTR regulation 
by intracellular pH may depend on the cell line and/or the approach 
used, which were both different in our work. 
To complement these data, it would be important to perform patch-
clamp experiments in human epithelial cells, in order to confirm our 
conclusions in physiologically relevant cells. Moreover, single-channel 
analysis would provide us valuable information about the behavior of 
this CFTR variant and its response to pH.  
 
Recently, CK2 has been considered a very interesting kinase that 
interacts with and regulates CFTR, with an hypothetical role in CFTR 
biogenesis, trafficking and function (Pagano et al., 2008) (Ostedgaard 
et al., 2006) (Luz, 2008)  
Here, we studied the effect of mutating three hypothetical CK2-
phosphosites (S422, S511 and T1471) upon CFTR function. 
We found that TBB inhibits wt-CFTR current but it does not affect 
F508del-CFTR. This is in agreement with previous work carried out in 
our group according to which TBB increases the turnover rate of wt-
CFTR and decreases its processing efficiency without any effect upon 
its mutant counterpart. (Luz, 2008) Altogether, these results suggest 
that if the observed effects upon wt-CFTR depend on direct 
phosphorylation by CK2, F508del-CFTR is not phosphorylated by CK2. 




Mutating S511 either into an A or a D did not have any appreciable 
effect upon wt-CFTR function, as it was expected since both mutants 
are fully processed and located at the plasma membrane (Luz, 2008). 
Moreover, these mutations did not affect F508del-CFTR currents, in 
Xenopus oocytes, despite its close proximity to F508del mutation. 
(Kunzelmann, 2009, personal communication). This is in agreement 
with the observation that S511 is not phosphorylated in vitro by CK2. 
(Pagano et al., 2008) 
Mutating S422, found to be phosphorylated in vitro (Pagano et al., 
2008), either into an alanine or an aspartate had a significant effect 
upon CFTR function as a Cl- channel, decreasing or increasing Gm, 
respectively. Although S422D presents higher Gm than wt-CFTR, there 
is still TBB inhibition, suggesting that this is not the only residue that is 
being phosphorylated by CK2 in vivo. 
Finally, both T1471A- and T1471D-CFTR were found here to be 
less functional than wt-CFTR. Because wt-T1471A-CFTR is fully 
processed (Luz, 2008), we believe that this mutation may alter channel 
gating.  
However, in Xenopus oocytes, T1471D-CFTR increases Gm, 
suggesting that a negative charge is essential to the proper gating of 
the channel and that this residue is probably phosphorylated in vivo. 
Nevertheless, we were not expecting to see any cAMP-activated 
current in oocytes since the processed form of this mutant could not be 
detected in mammalian cells by Western blot or by the sensitive 
technique of radiolabelling followed by immunoprecipitation (Luz, 
2008). However, it is already known fro long from expression of 
F508del-CFTR in Xenopus oocytes that in this system, the ERQC, is 
leakier than that of mammalian cells. (Drumm ML et al 1991) Similarly 




As for S422-, T1471A- and T1471D-CFTR, the respective currents 
are still inhibitable by TBB, which implies that these residues are not 
the only ones to be phosphorylated by CK2, in vivo. 
Since no function was detected in BHK cells for T1471D-CFTR 
using the iodide efflux technique, and according to the biochemical 
data above discussed (Luz, 2008), we are led to the conclusion that 
T1471 may be the major CK2-phosphorylation site. This site is highly 
interesting due to its proximity with CFTR C-terminus, which is 
responsible for several protein-protein interactions involved in CFTR 
trafficking and membrane stabilization. (Guggino and Stanton, 2006) 
To gain further mechanistic insight into CK2-CFTR interaction, it 
would be interesting to use double mutants, such as S422A/T1471A 
and S422D/T1471D, in order to study its biogenesis, trafficking and 
function.  
 
SYK, a tyrosine kinase with a hypothetical role in CFTR regulation 
putatively phosphorylates CFTR at residue Y512. By mutating wt-
CFTR at Y512, either to D, or F no significant effect resulted on the 
cAMP-activated current. However, for Y512A-CFTR, a significant 
increase in CFTR Gm was seen in both wt- and F508del backgrounds.  
This mutation is probably responsible for a conformational 
perturbation in the area around this residue because the alanine 
residue is both small and neutral. Luz studied the effect of this 
mutation upon a model of NBD1 structure and concluded that the 
replacement of tyrosine 512 in both wt- and F508del-CFTR by an 
alanine represents an alteration in the overall structure of NBD1. (Luz, 
2008). Such conformational change probably facilitates channel gating 
thus increasing cAMP-activated currents. Therefore, the Y512 residue, 
which is in close proximity to F508del, seems to play a very important 
role in the activation of the channel.  
To complement this work, it would be very interesting to analyse 
the effects of a specific SYK inhibitor, which together with in vitro 




phosphorylation assays could allow us to conclude whether the Y512 
site is indeed phosphorylated by this kinase. The latter is currently 
being performed in collaborative work with Paulo Matos at INSA,. 
Moreover, it is still necessary to study the effects of Y512F in 
biogenesis and trafficking of both wt- and F508del-CFTR to in order to 
fully understand the interaction between SYK and CFTR, and its 
dependency on residue Y512. 
 
Recently, we have started studying the effect of other kinases on 
CFTR traffic and function, namely the LMTK2 (Lemur Tyrosine Kinase 
2), a transmembrane protein with kinase activity described to form 
regulatory complexes at the membrane. This protein has been found to 
phosphorylate CFTR R-domain and directly bind to myosin VI, an 
actin-based retrograde motor protein that plays a crucial role in 
membrane trafficking pathways, and shown to facilitate CFTR 
endocytosis. (Wang and Brautigan 2002), (Wang and Brautigan 2006) 
(Swiatecka-Urban et al, 2004). Future work will focus on characterizing 
the functional interaction of CFTR and this kinase, which is highly 
relevant since we show here that it is expressed in human bronchial 
epithelial cells. (Chapter III – Section 4) 
 
In conclusion, here we studied the effects of CFTR phosphorylation, 
by major kinases, in order to better understand the mechanisms that 
regulate its biogenesis, trafficking and function. By functionally 
characterizing the role of these specific protein interactors, we expect 
to provide a novel insights that will help in the design of novel 
therapeutic strategies that will ultimately improve life expectancy and 
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pBluescript plasmid map showing its relevant elements (Stratagene): a 
Multiple cloning site (MCS) containing: T7 and T3 promoters which allow in 
vitro transcription while f1 origin of replication allows single-strand 
transcription. The pUC backbone includes ampicillin resistance for bacterial 
selection, under the control of a SV40 promoter. This plasmid also contains a 
lacZ gene encoding the N-terminal fragment of β-galactosidase, which allows 
blue-white screening of recombinant phagemids. 
  
 
